New Silkroutes Group Limited (NSG), a Singaporean investment holding company, has signed a Memorandum of Understanding (MOU) with Acclivis Technologies and Solutions Pte. Ltd. (Acclivis) to design and develop a comprehensive workflow for a cloudbased artificial intelligence (AI) platform that can be used to provide genomic-driven healthcare.
According to the agreement, Acclivis will also help to build a private AI cloud facility and develop a secure network connection within NSG’s operational facilities.
NSG’s healthcare subsidiary, Healthsciences International Pte. Ltd (HSI), owns and operates primary care, medical and dental clinics in Singapore with plans to expand into other South East Asian markets through acquisitions and partnerships.
With the upcoming AI platform, NSG will be able to pull genomics data from cloud data storage for use in different data analysis modules. The system will then produce customized clinical reports for medical practitioners. As the system has machine learning capability, it should become more intelligent with time and increased utilization.
NSG’s Chief Executive Officer VicPearly Wong said, “We have been working hard to enhance our AI capabilities to transform ourselves into a tech-enabled healthcare group that will provide patients with the best diagnosis and treatment. We look forward to launching GEIATM, our very own AI solution soon. GEIATM is a complete and seamless, hybrid cloud-based workflow platform solution with AI-optimized analyses.”
(Sources: New Silkroutes Group; BioSpectrum Asia; healthcare Global Magazine)
